These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 29032737)
1. Melanoma: a prototype of cancer-testis antigen-expressing malignancies. Faramarzi S; Ghafouri-Fard S Immunotherapy; 2017 Oct; 9(13):1103-1113. PubMed ID: 29032737 [TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck. Veit JA; Heine D; Thierauf J; Lennerz J; Shetty S; Schuler PJ; Whiteside T; Beutner D; Meyer M; Grünewald I; Ritter G; Gnjatic S; Sikora AG; Hoffmann TK; Laban S Head Neck; 2016 Jul; 38(7):1008-16. PubMed ID: 26874246 [TBL] [Abstract][Full Text] [Related]
3. Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers. Park TS; Groh EM; Patel K; Kerkar SP; Lee CC; Rosenberg SA J Immunother; 2016 Jan; 39(1):1-7. PubMed ID: 26641256 [TBL] [Abstract][Full Text] [Related]
4. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives. Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J Front Immunol; 2018; 9():947. PubMed ID: 29770138 [TBL] [Abstract][Full Text] [Related]
5. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck. Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: immunotherapeutic implications. Coral S; Sigalotti L; Colizzi F; Spessotto A; Nardi G; Cortini E; Pezzani L; Fratta E; Fonsatti E; Di Giacomo AM; Nicotra MR; Natali PG; Altomonte M; Maio M J Cell Physiol; 2006 Apr; 207(1):58-66. PubMed ID: 16252259 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer. Laban S; Atanackovic D; Luetkens T; Knecht R; Busch CJ; Freytag M; Spagnoli G; Ritter G; Hoffmann TK; Knuth A; Sauter G; Wilczak W; Blessmann M; Borgmann K; Muenscher A; Clauditz TS Int J Cancer; 2014 Sep; 135(5):1142-52. PubMed ID: 24482145 [TBL] [Abstract][Full Text] [Related]
9. Expression of cancer/testis antigens in cutaneous melanoma: a systematic review. Tio D; Kasiem FR; Willemsen M; van Doorn R; van der Werf N; Hoekzema R; Luiten RM; Bekkenk MW Melanoma Res; 2019 Aug; 29(4):349-357. PubMed ID: 30615012 [TBL] [Abstract][Full Text] [Related]
10. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers. Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913 [TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer. Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258 [TBL] [Abstract][Full Text] [Related]
12. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma. Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731 [TBL] [Abstract][Full Text] [Related]
13. Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy? Tessari A; Pilla L; Silvia D; Duca M; Paolini B; Carcangiu ML; Mariani L; de Braud FG; Cresta S Breast; 2018 Dec; 42():68-73. PubMed ID: 30189381 [TBL] [Abstract][Full Text] [Related]
14. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy. Gordeeva O Semin Cancer Biol; 2018 Dec; 53():75-89. PubMed ID: 30171980 [TBL] [Abstract][Full Text] [Related]
15. Lack of XAGE-1b and NY-ESO-1 in metastatic lymph nodes may predict the potential survival of stage III melanoma patients. Mori M; Funakoshi T; Kameyama K; Kawakami Y; Sato E; Nakayama E; Amagai M; Tanese K J Dermatol; 2017 Jun; 44(6):671-680. PubMed ID: 28105694 [TBL] [Abstract][Full Text] [Related]
16. Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application. Wei R; Dean DC; Thanindratarn P; Hornicek FJ; Guo W; Duan Z Cancer Lett; 2020 Jun; 479():54-60. PubMed ID: 31634526 [TBL] [Abstract][Full Text] [Related]